Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to HostWebcast to Discuss Aclidinium Bromide Data Presentations at theAmerican Thoracic Society Annual Congress
NEW YORK and BARCELONA, Spain, May 15, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. , and Laboratorios Almirall, S.A. (ALM.MC) will host a webcast to discuss aclidinium bromide clinical and pre-clinical data findings presented at the American Thoracic Society Annual Congress. The webcast, which will include a slide presentation and a Q&A session, will occur on Wednesday, May 21, 2008 at 9:30am New York time, 3:30pm CET, 2:30pm UKT.
Representing Almirall will be Per-Olof Andersson, Executive Director, Research and Development, Gonzalo de Miquel, Global Medical Director and Jordi Beleta, Director of Biology of Almirall. Representing Forest Laboratories will be Dr. Lawrence Olanoff, President and Chief Operating Officer of Forest.
Live audio-only access to the webcast can be obtained by dialing the following phone numbers:
For U.S. participants: 866.831.6162 For all international participants: +617.213.8852
A replay of the webcast will be available on both websites.
An audio-only replay will be available until May 28, 2008 and can be accessed by dialing the following phone numbers: The passcode is 52634048
For U.S. participants: 888-286-8010 For all international participants: + 617-801-6888
CONTACT: Charles Triano, Vice President - Investor Relations of ForestLaboratories, Inc., +1-212-224-6714, ; or JordiMolina, Head of Investor Relations of Almirall, S.A., +(34)-93-291-30-87, email@example.com firstname.lastname@example.org
Web site: http://www.almirall.com/
Ticker Symbol: (NYSE:FRX)
Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
Posted: May 2008